Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
97 participants
INTERVENTIONAL
2014-11-30
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dermatologists' Educational Demonstration for Epiduo Application
NCT02192632
Efficacy of Epiduo and Treatment Adherence of Adolescent Patients With Inflammatory Acne
NCT01220102
Effect of Samples on Acne Treatment With Epiduo® Gel
NCT01504204
A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris
NCT06671834
Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes
NCT00907101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of care + supplementary education
Subjects will receive supplementary patient educational material in addition to standard-of-care instructions.
Standard of care + supplementary education
Standard of care
Subjects will receive standard-of-care instructions only.
Standard of care
Standard of care + additional visits
Subjects will receive standard-of-care instructions, and two additional clinical visits.
Standard of care + additional visits
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard of care + supplementary education
Standard of care + additional visits
Standard of care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. With facial acne vulgaris that can be managed in primary care
Exclusion Criteria
2. Subjects have a very severe variant of acne such as fulminating acne with systemic symptoms (acne fulminans)
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Swan Lane Medical Centre
Bolton, , United Kingdom
Burbage Surgery
Burbage, , United Kingdom
South Axholme Practice
Epworth, , United Kingdom
Dr Moss and Partners
Harrogate, , United Kingdom
Barlow Medical Centre
Manchester, , United Kingdom
Leicester Terrace Health Care Centre
Northampton, , United Kingdom
University of Nottingham Health Service
Nottingham, , United Kingdom
Rothwell and Desborough Healthcare Group
Rothwell, , United Kingdom
Albany House Medical Centre
Wellingborough, , United Kingdom
Whitby Group Practice
Whitby, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Myhill T, Coulson W, Nixon P, Royal S, McCormack T, Kerrouche N. Use of Supplementary Patient Education Material Increases Treatment Adherence and Satisfaction Among Acne Patients Receiving Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in Primary Care Clinics: A Multicenter, Randomized, Controlled Clinical Study. Dermatol Ther (Heidelb). 2017 Dec;7(4):515-524. doi: 10.1007/s13555-017-0203-4. Epub 2017 Oct 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD.03.SPR.102710
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.